✦ LIBER ✦

Overexpression of MET is a new predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-typeKRAS

✍ Scribed by Kishiki, Tomokazu; Ohnishi, Hiroaki; Masaki, Tadahiko; Ohtsuka, Kouki; Ohkura, Yasuo; Furuse, Jyunji; Watanabe, Takashi; Sugiyama, Masanori

Book ID: 121557946
Publisher: Springer
Year: 2014
Tongue: English
Weight: 572 KB
Volume: 73
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-014-2401-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

LMO1 is a novel oncogene in colorectal c

LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy

✍ Liu, Junguang; Yan, Peiyun; Jing, Niancai; Yang, Jili 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 346 KB

LMO1 is a novel oncogene in lung cancer,

LMO1 is a novel oncogene in lung cancer, and its overexpression is a new predictive marker for anti-EGFR therapy

✍ Yue Zhang,Jili Yang,Jun Wang,Huaiyu Guo,Niancai Jing 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 231 KB

Predictive markers for anti-EGFR antibod

Predictive markers for anti-EGFR antibodies in colorectal cancer: the beginning of a new era

✍ Eric Van Cutsem; Sabine Tejpar 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 72 KB